Angiochem

This company develops pharmaceutical drugs for central nervous system (CNS) diseases, including brain cancer, brain metastases, lysosomal storage diseases, and pain. Their drugs aim to provide healthcare professionals with effective treatments for a range of brain-related disorders.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

This company develops pharmaceutical drugs for central nervous system (CNS) diseases, including brain cancer, brain metastases, lysosomal storage diseases, and pain. Their drugs aim to provide healthcare professionals with effective treatments for a range of brain-related disorders.